Clinical Trials Directory

Trials / Completed

CompletedNCT01590121

Hereditary Haemorrhagic Telangiectasia Flight Safety Study

A Questionnaire Based Study to Evaluate the Safety of Flying in Hereditary Haemorrhagic Telangiectasia (HHT)

Status
Completed
Phase
Study type
Observational
Enrollment
156 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
16 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Hereditary Haemorrhagic Telangiectasia (HHT) is a condition in which sufferers have abnormal blood vessels which makes them more likely to bleed than other people, particularly in the lungs, which results in low blood oxygen levels. Flying may make this worse and cause problems. The investigators want to know if there are an increased number of problems on flights compared to on land. The investigators currently do not have any evidence based guidelines on air travel to best advice people who suffer with HHT. The investigators would therefore like to ask individuals who have HHT about their experience on a flight, using a postal questionnaire.

Detailed description

Individuals with Hereditary Haemorrhagic Telangiectasia (HHT) previously reviewed at HHTIC London will be sent an invitation to participate in a short questionnaire study. Quantitative variables from the questionnaires for statistical analysis will be the number of individuals responding (and number of questionnaires sent out); number of flights taken and number of complications, subgrouped by type, and flight duration in hours. Complication rates will be expressed as proportion of person flight hours. The quantitative data from the questionnaire will then be compared with quantitative data from patients' medical records using non parametric methods such as Mann Whitney for univariate analyses.

Conditions

Interventions

TypeNameDescription
OTHERAeroplane flight in the past- no active intervention for studyAeroplane flight(s) previously taken by study participants
OTHERQuestionnaireFlight by aeroplane (previous)

Timeline

Start date
2010-01-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2012-05-02
Last updated
2024-11-12
Results posted
2024-11-12

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01590121. Inclusion in this directory is not an endorsement.